Stock Trend Analysis Report
Prepared for you on Wednesday, May 27, 2020.
Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Long-Term Uptrend (+90) - ZYNE is in a strong uptrend that is likely to continue. While ZYNE is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid ZYNE?
MarketClub looks at technical strength and momentum to determine if the timing is right for ZYNE.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for ZYNE
The long-term trend has been UP since May 21st, 2020 at 5.45
The intermediate-term trend has been UP since Apr 27th, 2020 at 4.18
The short-term trend has been UP since May 18th, 2020 at 4.34
Smart Scan Analysis for ZYNE
Based on our trend formula, ZYNE is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|Year High||14.45||Year High Date||2018-01-03|
|Year Low||4.5||Year Low Date||2018-11-28|
|52wk High||16.47||52wk High Date||2019-05-17|
|52wk Low||2.55||52wk Low Date||2020-03-17|
|Average Volume||560,460||Shares Outstanding||23,556|